Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Aignostics-SeriesB-AI

More Like This

PR Newswire associated0

Aignostics Announces Results for Pathology Foundation Model Developed in Collaboration with Mayo Clinic

Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology

Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare

PR Newswire associated0

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

PR Newswire associated0

AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI

UK-backed AI companies to transform British cancer care and spark new drug breakthroughs

PR Newswire associated0

Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment

PR Newswire associated0

Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI